Genus plc (LON:GNS)
London · Delayed Price · Currency is GBP · Price in GBX 2,645.00
-25.00 (-0.94%)
Mar 9, 2026, 4:47 PM GMT
Genus Market Cap
Genus has a market cap or net worth of 1.79 billion as of March 9, 2026. Its market cap has increased by 50.92% in one year.
Market Cap
1.79B
Enterprise Value
2.00B
Revenue
672.00M
Ranking
n/a
PE Ratio
37.69
Stock Price
2,645.00
Market Cap Chart
Since January 30, 1998, Genus's market cap has increased from 31.03M to 1.79B, an increase of 5,657.54%. That is a compound annual growth rate of 15.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.79B | 2.89% |
| Dec 31, 2025 | 1.74B | 70.54% |
| Dec 31, 2024 | 1.02B | -28.43% |
| Dec 29, 2023 | 1.42B | -27.10% |
| Dec 30, 2022 | 1.95B | -39.35% |
| Dec 31, 2021 | 3.22B | 18.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oxford Nanopore Technologies | 1.18B |
| Oxford Biomedica | 771.17M |
| Avacta Group | 310.56M |
| PureTech Health | 298.88M |
| Scancell Holdings | 133.35M |
| 4basebio | 83.58M |
| Bioventix | 80.99M |
| Hemogenyx Pharmaceuticals | 63.84M |